---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-041604"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2026-04-09T23:59:59+00:00"
generated_at: "2026-05-15T06:46:58.582923+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx appoints Microsoft Health COO Mary Varghese Presti to board

## Summary
- Mary Varghese Presti appointed independent director effective April 3, 2026; board expanded to 7 members.
- She serves on Audit Committee; receives $45k annual cash retainer plus $175k equity grant and $10k audit fee.
- Varghese Presti is Microsoft Corporate VP & COO, Health & Life Sciences, with 25+ years in healthcare/tech.
- CEO cites her experience in M&A, platform scaling, and commercialization as aligning with OptimizeRx strategy.

## SEC filing metadata
- accession: 0001213900-26-041604
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2026-04-09T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390026041604/0001213900-26-041604-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390026041604/ea0285473-8k_optimize.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-041604
- JSON: https://secwatch.observer/filing/0001213900-26-041604.json
- Plain text: https://secwatch.observer/filing/0001213900-26-041604.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.